HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David M Goldenberg Selected Research

Complement System Proteins (Complement)

5/2010Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects.
1/2009Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.
4/2005Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
4/2004Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David M Goldenberg Research Topics

Disease

194Neoplasms (Cancer)
02/2024 - 01/2002
47Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2015 - 05/2002
36Lymphoma (Lymphomas)
01/2015 - 05/2002
21Neoplasm Metastasis (Metastasis)
01/2021 - 02/2002
15Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 02/2002
15Pancreatic Neoplasms (Pancreatic Cancer)
09/2015 - 05/2002
13Carcinoma (Carcinomatosis)
02/2024 - 06/2002
13Colonic Neoplasms (Colon Cancer)
06/2018 - 04/2005
12B-Cell Lymphoma (Lymphoma, B Cell)
10/2013 - 05/2002
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2006
10Triple Negative Breast Neoplasms
02/2024 - 03/2014
9Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 01/2002
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 08/2008
9Multiple Myeloma
01/2018 - 10/2004
9Hematologic Neoplasms (Hematological Malignancy)
07/2015 - 05/2002
8Breast Neoplasms (Breast Cancer)
02/2024 - 03/2004
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 08/2007
8Adenocarcinoma
09/2015 - 12/2007
8Prostatic Neoplasms (Prostate Cancer)
02/2015 - 01/2007
7Autoimmune Diseases (Autoimmune Disease)
01/2014 - 10/2006
6medullary Thyroid cancer
11/2020 - 12/2004
6Leukemia
01/2014 - 09/2008
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 08/2004
5Neoplasm Micrometastasis
01/2017 - 10/2003
5Burkitt Lymphoma (Burkitt's Lymphoma)
01/2015 - 12/2005
5Renal Cell Carcinoma (Grawitz Tumor)
04/2013 - 09/2003
4Neutropenia
01/2021 - 09/2015
4Diarrhea
01/2021 - 09/2015
4Disease Progression
01/2021 - 06/2010
4Body Weight (Weight, Body)
01/2019 - 01/2003
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2012 - 06/2010
3Residual Neoplasm
12/2019 - 04/2005
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2016 - 05/2010
3Stomach Neoplasms (Stomach Cancer)
01/2016 - 10/2014

Drug/Important Bio-Agent (IBA)

65Monoclonal AntibodiesIBA
01/2021 - 01/2002
46AntibodiesIBA
06/2015 - 05/2002
45Peptides (Polypeptides)IBA
01/2021 - 05/2002
39Carcinoembryonic AntigenIBA
01/2021 - 02/2002
38AntigensIBA
01/2020 - 01/2002
36Radioisotopes (Radionuclides)IBA
01/2017 - 05/2002
35Immunoconjugates (Immunoconjugate)IBA
01/2021 - 11/2003
30epratuzumabIBA
01/2018 - 01/2003
28Immunoglobulin G (IgG)IBA
09/2019 - 04/2002
26HaptensIBA
02/2015 - 09/2003
22Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 04/2005
21sacituzumab govitecanIBA
02/2024 - 05/2015
18veltuzumabIBA
11/2016 - 04/2004
16Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2003
15Rituximab (Mabthera)FDA Link
12/2014 - 04/2004
13milatuzumabIBA
01/2021 - 12/2004
12AcidsIBA
01/2017 - 09/2003
12Bispecific AntibodiesIBA
02/2015 - 05/2002
10Pentetic Acid (DTPA)FDA LinkGeneric
09/2019 - 01/2003
10HLA-DR Antigens (HLA-DR)IBA
01/2018 - 01/2005
101,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017 - 01/2003
9DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2021 - 04/2010
8GemcitabineFDA Link
08/2022 - 11/2004
8Biomarkers (Surrogate Marker)IBA
10/2020 - 12/2007
8Glycine (Aminoacetic Acid)FDA LinkGeneric
09/2019 - 11/2005
8Histamine (Histamine Dihydrochloride)FDA Link
09/2019 - 11/2005
7labetuzumabIBA
02/2017 - 12/2004
6Doxorubicin (Adriamycin)FDA LinkGeneric
06/2013 - 04/2005
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2020 - 10/2006
5MucinsIBA
09/2015 - 12/2009
5clivatuzumabIBA
02/2015 - 12/2009
5EpitopesIBA
02/2015 - 10/2005
4Surface Antigens (Surface Antigen)IBA
01/2021 - 05/2002
4DNA (Deoxyribonucleic Acid)IBA
10/2020 - 07/2012
4ProdrugsIBA
01/2020 - 11/2008
4procaine isothiocyanate (PRIT)IBA
01/2017 - 11/2010
4CytokinesIBA
10/2014 - 05/2002
4EnzymesIBA
02/2013 - 01/2006
4Immunotoxins (Immunotoxin)IBA
07/2012 - 05/2005
4IsotopesIBA
06/2012 - 11/2003
4Ribonucleases (Ribonuclease)IBA
08/2010 - 05/2002
4Complement System Proteins (Complement)IBA
05/2010 - 04/2004
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2007 - 04/2002
4Immunoglobulin Fab FragmentsIBA
05/2006 - 04/2002
3Topoisomerase I InhibitorsIBA
01/2021 - 11/2008
3Immunoglobulins (Immunoglobulin)IBA
08/2019 - 10/2010
3labetuzumab govitecanIBA
01/2018 - 06/2015
3Messenger RNA (mRNA)IBA
01/2016 - 04/2002
3YttriumIBA
09/2015 - 01/2003
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2015 - 04/2009
3Therapeutic UsesIBA
12/2012 - 09/2003
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
08/2012 - 06/2012
3Humanized Monoclonal AntibodiesIBA
10/2010 - 05/2005
3SphingomyelinsIBA
06/2009 - 02/2002
3CeramidesIBA
06/2009 - 11/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 04/2002
3IodineIBA
06/2005 - 03/2004
2PlatinumIBA
02/2024 - 02/2016
2human ERBB2 proteinIBA
02/2024 - 01/2020

Therapy/Procedure

109Therapeutics
03/2020 - 02/2002
71Radioimmunotherapy
02/2017 - 01/2002
26Drug Therapy (Chemotherapy)
02/2024 - 01/2002
13Immunotherapy
06/2018 - 01/2003
4Computer-Assisted Surgery (Image Guided Surgery)
04/2020 - 09/2014
4Subcutaneous Injections
11/2016 - 05/2010
4Radiotherapy
04/2013 - 05/2005